NO20000737L - Tetrahydro <gamma>-karboliner - Google Patents

Tetrahydro <gamma>-karboliner

Info

Publication number
NO20000737L
NO20000737L NO20000737A NO20000737A NO20000737L NO 20000737 L NO20000737 L NO 20000737L NO 20000737 A NO20000737 A NO 20000737A NO 20000737 A NO20000737 A NO 20000737A NO 20000737 L NO20000737 L NO 20000737L
Authority
NO
Norway
Prior art keywords
optionally substituted
6alkyl
aryl
carbolines
tetrahydro
Prior art date
Application number
NO20000737A
Other languages
English (en)
Other versions
NO20000737D0 (no
NO315236B1 (no
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20000737D0 publication Critical patent/NO20000737D0/no
Publication of NO20000737L publication Critical patent/NO20000737L/no
Publication of NO315236B1 publication Critical patent/NO315236B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20000737A 1997-09-08 2000-02-14 Tetrahydro gamma-karboliner, deres fremstilling og farmasöytiske sammensetninger inneholdende det samme NO315236B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202761A EP0905136A1 (en) 1997-09-08 1997-09-08 Tetrahydro gamma-carbolines
PCT/EP1998/005710 WO1999012926A1 (en) 1997-09-08 1998-09-01 Tetrahydro gamma-carbolines

Publications (3)

Publication Number Publication Date
NO20000737D0 NO20000737D0 (no) 2000-02-14
NO20000737L true NO20000737L (no) 2000-05-08
NO315236B1 NO315236B1 (no) 2003-08-04

Family

ID=8228715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000737A NO315236B1 (no) 1997-09-08 2000-02-14 Tetrahydro gamma-karboliner, deres fremstilling og farmasöytiske sammensetninger inneholdende det samme

Country Status (27)

Country Link
US (2) US6303614B1 (no)
EP (2) EP0905136A1 (no)
JP (1) JP2001515899A (no)
KR (1) KR100603896B1 (no)
CN (1) CN1110496C (no)
AT (1) ATE243209T1 (no)
AU (1) AU752410B2 (no)
BR (1) BR9811769A (no)
CA (1) CA2301807A1 (no)
CZ (1) CZ297220B6 (no)
DE (1) DE69815700T2 (no)
EE (1) EE04496B1 (no)
ES (1) ES2202902T3 (no)
HR (1) HRP20000108A2 (no)
HU (1) HUP0003577A3 (no)
ID (1) ID23954A (no)
IL (1) IL134894A (no)
MY (1) MY129176A (no)
NO (1) NO315236B1 (no)
NZ (1) NZ503096A (no)
PL (1) PL191863B1 (no)
RU (1) RU2208614C2 (no)
SK (1) SK285594B6 (no)
TR (1) TR200000616T2 (no)
TW (1) TW531539B (no)
WO (1) WO1999012926A1 (no)
ZA (1) ZA988161B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG146683A1 (en) 2003-09-17 2008-10-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
UA85563C2 (ru) * 2003-09-17 2009-02-10 Янссен Фармацевтика Н.В. Конденсированные гетероциклические соединения
EP1944306A1 (en) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as serotonin receptor modulators
JP4816453B2 (ja) * 2004-04-12 2011-11-16 大正製薬株式会社 環状アミン化合物
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
FR2885905A1 (fr) * 2005-05-23 2006-11-24 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament
WO2007009485A1 (en) * 2005-07-22 2007-01-25 Pharma C S.A. Substituted 8-phenoxy-y-carboline derivatives with 5ht1 activity
WO2007058580A1 (en) * 2005-11-15 2007-05-24 Astrazeneca Ab Novel 2-aminopyrimidinone derivatives and their use
US20080083807A1 (en) * 2006-10-06 2008-04-10 Beardsley John W Surgical instrument including a locking assembly
AU2008302751A1 (en) * 2007-09-20 2009-03-26 D2E, Llc Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use
EP2236511A4 (en) 2007-12-21 2011-04-13 Alla Chem Llc LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF
RU2374245C1 (ru) 2008-08-22 2009-11-27 Андрей Александрович Иващенко Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство
CN105399674B (zh) 2015-12-31 2017-02-15 青岛清原化合物有限公司 吡唑类化合物或其盐、制备方法、除草剂组合物及用途
CN106631941B (zh) * 2016-12-30 2018-09-28 青岛瀚生生物科技股份有限公司 一种2-甲基-3氯苯基甲硫醚的制备方法
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
CN110698474B (zh) * 2019-11-14 2021-11-02 福州大学 一种α位取代四氢-γ-咔啉类化合物及其制备方法和应用
US20230339949A1 (en) * 2020-10-09 2023-10-26 Shujing Biopharma Co., Ltd HETEROCYCLIC SUBSTITUTED FUSED y-CARBOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410286C2 (de) * 1984-03-21 1986-01-23 Fresenius AG, 6380 Bad Homburg Verfahren zur Trennung von Blut sowie Vorrichtung zur Durchführung des Verfahrens
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
RU2067980C1 (ru) * 1992-06-30 1996-10-20 Глэксо Груп Лимитед Производные лактама и фармацевтическая композиция, являющаяся антагонистом 5-окситраптамина /5-нт/ на 5- нт3 -рецепторах или их физиологически приемлемые соли и соловаты
ES2204932T3 (es) * 1994-09-12 2004-05-01 Eli Lilly And Company Limited Moduladores serotonergicos.

Also Published As

Publication number Publication date
AU752410B2 (en) 2002-09-19
DE69815700D1 (en) 2003-07-24
PL191863B1 (pl) 2006-07-31
PL339143A1 (en) 2000-12-04
TW531539B (en) 2003-05-11
RU2208614C2 (ru) 2003-07-20
CZ2000726A3 (cs) 2000-07-12
KR100603896B1 (ko) 2006-07-25
IL134894A (en) 2005-03-20
CA2301807A1 (en) 1999-03-18
EE04496B1 (et) 2005-06-15
CN1269800A (zh) 2000-10-11
EP0905136A1 (en) 1999-03-31
ES2202902T3 (es) 2004-04-01
NO20000737D0 (no) 2000-02-14
SK2992000A3 (en) 2001-03-12
DE69815700T2 (de) 2004-04-29
CN1110496C (zh) 2003-06-04
JP2001515899A (ja) 2001-09-25
AU9742198A (en) 1999-03-29
TR200000616T2 (tr) 2000-07-21
WO1999012926A1 (en) 1999-03-18
US20020103209A1 (en) 2002-08-01
CZ297220B6 (cs) 2006-10-11
ID23954A (id) 2000-06-08
EP1015451A1 (en) 2000-07-05
SK285594B6 (sk) 2007-04-05
BR9811769A (pt) 2000-08-29
US6506768B2 (en) 2003-01-14
ZA988161B (en) 2000-03-22
HRP20000108A2 (en) 2000-12-31
HK1029107A1 (en) 2001-03-23
KR20010022391A (ko) 2001-03-15
US6303614B1 (en) 2001-10-16
NO315236B1 (no) 2003-08-04
EE200000059A (et) 2000-10-16
ATE243209T1 (de) 2003-07-15
HUP0003577A3 (en) 2003-05-28
NZ503096A (en) 2001-11-30
MY129176A (en) 2007-03-30
HUP0003577A2 (hu) 2001-09-28
EP1015451B1 (en) 2003-06-18
IL134894A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
NO20000737D0 (no) Tetrahydro &lt;gamma&gt;-karboliner
MXPA03011244A (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6.
DK0378255T3 (da) 2-aminopyrimidinoderivater
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
NL300298I1 (nl) Nieuwe 3-piperidinyl-1,2-benzisoxazolen
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
NO20025640D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
DE3585990D1 (de) Derivate von hydroxy- oder amino-substituierten piperidinylalkylchinazolinen.
EP0604354A3 (en) Antidepressant and anti-Parkinson&#39;s disease compounds.
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
ATE169015T1 (de) Aminobenzoesäure derivate
DE68923231D1 (de) Antihypertensive 3-Piperidinylindazol-Derivate.
ATE85056T1 (de) Tetracyclische indolderivate.
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.